Reska Biotech
GWIN · OTC
$0.6591+$0.526 (+395.19%)TodayMarket closed ·
No price history for this range.
Key indicators
GWIN profitability and balance sheet ratios
EPS -$0.0001 in Jun 2017, against -$0.0005 a year earlier.
| Period | EPS |
|---|---|
| Jun 2015 | $0.0589 |
| Sep 2015 | $0.0426 |
| Dec 2015 | $0.061 |
| Jun 2016 | -$0.0005 |
| Sep 2016 | -$0.0002 |
| Dec 2016 | -$0.0004 |
| Mar 2017 | -$0.0196 |
| Jun 2017 | -$0.0001 |
Income statement
No financial statements are reported for Reska Biotech.
Balance sheet
What the company owns and owes at period end
Total assets
Total liabilities
| Line item | Dec 2016 | Mar 2017 | Jun 2017 |
|---|---|---|---|
| Total assets | $0.0M | $0.0M | $0.0M |
| Total liabilities | $0.1M | $0.1M | $0.1M |
| Shareholder equity | −$0.1M | −$0.1M | −$0.1M |
| Cash and short-term investments | $0.0M | $0.0M | $0.0M |
| Total debt | $0.0M | $0.0M | $0.0M |
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.